What is AOR?
Founded in 1991, Advanced Orthomolecular Research (AOR) is a prominent player in the natural health industry, specializing in the development and manufacturing of evidence-based health products. The company focuses on formulations designed to support critical bodily systems, including cardiovascular, cognitive, digestive, and immune functions. AOR distinguishes itself through a commitment to scientific integrity, collaborating with research institutions to ensure the efficacy and quality of its diverse product range, which includes capsules, powders, and softgels. Their dedication to transparency and high-quality manufacturing caters to consumers seeking personalized and effective health solutions.
How much funding has AOR raised?
AOR has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for AOR?
The substantial backing indicated by $350K suggests AOR is in a mature growth phase, likely leveraging this capital for market expansion, further research and development into novel formulations, and potentially scaling its manufacturing capabilities. The recent strategic investment points towards a focused effort to enhance its market penetration and solidify its competitive advantage in the evidence-based natural health products arena.
See full AOR company page
